HCS HB 1534 -- LIFE SCIENCES RESEARCH (Lembke) COMMITTEE OF ORIGIN: Health Care Policy This substitute requires 25% of the funds received from subsequent participating manufacturers in the Tobacco Settlement Agreement that are deposited into the Life Sciences Research Trust Fund to be expended by the Life Sciences Research Board. The board is required to spend 25% of the moneys in the trust fund for the program that awards grants to establish and expand umbilical cord blood banks. The remaining 75% must fund life science research projects involving the study, use, or therapies involving human stem cells derived from non-embryonic and non-fetal sources. FISCAL NOTE: No impact on state funds in FY 2007, FY 2008, and FY 2009.